Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.

Bramwell, Vivien H C

Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2002 - 383-93 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1078-0432


ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Adult
Aged
Antibiotics, Antineoplastic--pharmacology
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Disease Progression
Disease-Free Survival
Doxorubicin--therapeutic use
Drug Resistance, Neoplasm
Female
Humans
Male
Middle Aged
Piperidines--pharmacokinetics
Pyridines--pharmacokinetics
Sarcoma--drug therapy
Soft Tissue Neoplasms--drug therapy
Time Factors